Article | May 6, 2026

Enhancing Safety In Drug Substance Synthesis: A Smart Approach To Chemical Design

Source: Ardena
pharma-manufacturing-GettyImages-2196233628

Scaling up drug substance synthesis often introduces safety risks linked to hazardous reagents, heat‑releasing reactions, and pressure buildup. Addressing these risks early requires a deep understanding of reaction behavior and a deliberate approach to process design. A safety‑by‑design strategy focuses on identifying hazardous transformations during route selection and modifying conditions before scale‑up begins. Tools such as reaction calorimetry and thermal analysis help quantify energy release, temperature rise, and the onset of unsafe events, enabling informed decisions on how reactions should be controlled. Techniques like dose‑controlled reagent addition, portion‑wise charging, reversed addition strategies, and solvent selection with higher heat capacity can dramatically improve process stability. Demonstration runs and gradual scale increases further validate that reactions remain controllable as volumes grow. By embedding safety considerations into chemical design rather than treating them as late‑stage checks, development teams can reduce operational risk, protect personnel and facilities, and create synthesis routes that are robust, scalable, and suitable for long‑term manufacturing.

access the Article!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Bioprocess Online? Subscribe today.

Subscribe to Bioprocess Online X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Bioprocess Online